Spectral Instruments Imaging manufactures instruments for preclinical optical (bioluminescent, fluorescent) and X-ray imaging.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
The roles of preclinical optical imaging in cancer research
Sep 22, 2021
Watch the last Spectral Instrument Imaging webinar with Dr. Michael Henry who will shares key data sets from his work...
See What's Possible with the PippinHT
Sep 14, 2021
Programmable DNA size selection enables new discoveries by helping optimize the library detected by a sequencer. That’s...
Magnetic resonance elastography techniques and preclinical applications
Sep 14, 2021
It has been known for centuries that tissue stiffness can change in the presence of disease, but quantifying such...
Ex Vivo dental imaging is directly translatable to the clinic
Sep 14, 2021
Although patients are too large in size for preclinical microCT scanners, it still has a big significance in clinical...
IncuCyte live cell analysis system for 3D Organoids discovery
Sep 10, 2021
Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...
Blood-Brain Barrier (BBB) - Pathophysiology in ischemic stroke
Aug 27, 2021
In-depth Understanding of Blood-Brain Barrier (BBB)
Introducing New Aura 4.0 software
Aug 27, 2021
With new features for both acquisition & analysis Aura Software enables you to capture and analyze your data quickly,...
Aug 19, 2021
Year after year, the Micro-CT User meeting showcases state-of-the-art applications in both life and material sciences,...
A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy
Sep 18, 2018
Antigen-specific cytotoxic T lymphocytes (CTLs), which eliminate target cells bearing antigenic peptides presented by surface major histocompatibility complex (MHC) class I molecules, play a key role in cancer immunotherapy. However, the majority of tumors are not immunologically rejected since they express self-antigens which are not recognized by CTLs as foreign. To foreignize these tumors for CTL-mediated immunological rejection, it is essential to develop carriers that can effectively deliver foreign antigens to cancer cells.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Get more info
Brand profile
